Pharma Investments, Ventures & Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Cellcom Israel Ltd.

Cellcom Israel Announces Denied Purported Class Action Returned for Further Consideration

today that the Israeli Supreme Court partially accepted an appeal filed on March 2006 against the denial of a purported class action lawsuit by the District Court of Tel Aviv-Jaffa and referred the purported class action for further consideration in the District Court, in relation to certain issues determined by the Supreme Court. The purported class action was filed in September 2000 against the Company in the District Court by one of the Company's subscribers in connection with VAT charges in respect of insurance premiums and the provision of insurance services that were allegedly not provided in accordance...

• View Other Issues of Pharma Investments, Ventures & Law Weekly
  
• View Other NewsRx Publications